` RFM (Sensorion SA) vs DAX Index Comparison - Alpha Spread

RFM
vs
D
DAX Index

Over the past 12 months, RFM has underperformed DAX Index, delivering a return of -48% compared to the DAX Index's +10% growth.

Stocks Performance
RFM vs DAX Index

Loading
RFM
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
RFM vs DAX Index

Loading
RFM
DAX Index
Difference
www.alphaspread.com

Performance By Year
RFM vs DAX Index

Loading
RFM
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sensorion SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sensorion SA
Glance View

Market Cap
82.9m EUR
Industry
Biotechnology

Sensorion SAS is a biopharmaceutical company, which engages in the development of therapies to treat and prevent diseases of the inner ear such as deafness, vertigo and tinnitus. The company is headquartered in Montpellier, Occitanie and currently employs 34 full-time employees. The company went IPO on 2015-04-21. The firm is principally active in the development of targeted therapeutic solutions to treat inner ear diseases. The firm develops also drug treatments, from molecular biology all the way to animal pharmacology, toxicology, and clinical research and therapeutic solutions to treat vestibular deficits. Sensorion SA is a spin-off of the research team Pathophysiology and Therapy of Vestibular Deficits in Montpellier Neuroscience Institute.

RFM Intrinsic Value
Not Available
Back to Top